Scryb Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Scryb Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Scryb Inc
CNSX:SCYB
Revenue
CA$429.6k
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Profound Medical Corp
TSX:PRN
Revenue
$16.1m
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Theralase Technologies Inc
XTSX:TLT
Revenue
CA$1m
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
-4%
MedMira Inc
XTSX:MIR
Revenue
CA$188.5k
CAGR 3-Years
-37%
CAGR 5-Years
-41%
CAGR 10-Years
-29%
O
Ondine Biomedical Inc
LSE:OBI
Revenue
CA$2m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Conavi Medical Corp
XTSX:CNVI
Revenue
$706k
CAGR 3-Years
N/A
CAGR 5-Years
-49%
CAGR 10-Years
N/A
No Stocks Found

Scryb Inc
Glance View

Market Cap
6.1m CAD
Industry
Health Care

Scryb, Inc. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. The company is headquartered in Etobicoke, Ontario. The Company’s platform offers businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The platform adopts across diverse markets, from digital health and diagnostics to cybersecurity and manufacturing. The Company’s cloud-based platform is composed of elements including sensor technology, Internet of things (IoT), predictive analytics, and computer vision. Its portfolio includes Pharmatrac, Fionet, Handheld Diagnostics and Cybeats. Pharmatrac is an artificial intelligence (AI) digital health company that provides insight into medication behavior. Fionet is a data-and-device platform that enables controlled testing and tracking for pandemic response. Handheld Diagnostics brings lab-quality analysis to bedside in critical care situations. Cybeats builds certainty in software security.

SCYB Intrinsic Value
0.01 CAD
Overvaluation 89%
Intrinsic Value
Price CA$0.13
S

See Also

What is Scryb Inc's Revenue?
Revenue
429.6k CAD

Based on the financial report for Sep 30, 2025, Scryb Inc's Revenue amounts to 429.6k CAD.

What is Scryb Inc's Revenue growth rate?
Revenue CAGR 3Y
-13%

Over the last year, the Revenue growth was -77%. The average annual Revenue growth rates for Scryb Inc have been -13% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett